http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2358657-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47ab7168b57b9095e02471b569c7e5a4 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B10-00 |
| filingDate | 2007-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ce70a15d9892e807a6900cb2f1b1365 |
| publicationDate | 2009-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2358657-C2 |
| titleOfInvention | Hyperfibrinolysis prediction and diagnostic technique |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely to haemostasis and fibrinolysis system analysis methods. Coagulation properties of two citrated blood samples are analysed simultaneously by re-calcification with kaolin added. One blood sample is added with plasmin in amount 1.5 times extending coagulation time as compared to the reference thus calculating the coagulation prolongation percentage by formula: where t with plasm is coagulation time with plasmin, t without plasm is coagulation time without plasmin. The coagulation prolongation percentage is compared to the reference results in hyperfibrinolysis prediction and diagnostics. n EFFECT: method provides improved quality of treatment ensured by higher diagnostic accuracy and possibility to predict thromboses and haemorrhages in surgical, therapeutic and neurologic patients. n 3 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2618402-C1 |
| priorityDate | 2007-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.